• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾周脂肪或肾上腺受累对pT3b期肾细胞癌患者的预后影响

Prognostic impact of perirenal fat or adrenal gland involvement in patients with pT3b renal cell carcinoma.

作者信息

Fujita Tetsuo, Iwamura Masatsugu, Yanagisawa Nobuyuki, Muramoto Masatoshi, Hirayama Takahiro, Okayasu Isao, Baba Shiro

机构信息

Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

出版信息

Urology. 2007 May;69(5):839-42. doi: 10.1016/j.urology.2007.01.035.

DOI:10.1016/j.urology.2007.01.035
PMID:17482918
Abstract

OBJECTIVES

To analyze the prognostic impact of the pT3a factors, perirenal fat or adrenal gland involvement, in patients with pT3b renal cell carcinoma (RCC).

METHODS

A total of 43 patients with pT3b RCC who underwent radical nephrectomy, with complete resection of tumor thrombus, at our institution from March 1972 to September 2005 were enrolled in this study. The presence of pT3a factors was reviewed, and the disease-specific survival was compared according to the reclassification as pT3b only or pT3b with pT3a.

RESULTS

After review by a single pathologist, 23 patients (53.5%) were identified as having pT3b only and 20 patients (46.5%) as having pT3b with pT3a. The mean disease-specific survival time in those with pT3b only was significantly longer at 70.9 +/- 9.1 (SE) months compared with 25.0 +/- 4.4 (SE) months in those with pT3b with pT3a (P = 0.0032). On univariate analyses, the presence of pT3a factors (P = 0.0065), preoperative metastasis (P = 0.0025), surgical specimens positive for lymph node metastasis (P = 0.0183), and spindle cell factor (P = 0.0233) were recognized as predictors of a poor prognosis.

CONCLUSIONS

The presence of perirenal fat or adrenal gland involvement in patients with pT3b RCC renders the prognosis significantly worse. Careful postoperative examination should be required, along with reclassification for Stage pT3b with pT3a in RCC.

摘要

目的

分析pT3a因素(肾周脂肪或肾上腺受累)对pT3b期肾细胞癌(RCC)患者预后的影响。

方法

本研究纳入了1972年3月至2005年9月期间在我院接受根治性肾切除术且肿瘤血栓完全切除的43例pT3b期RCC患者。回顾pT3a因素的存在情况,并根据重新分类为仅pT3b或伴有pT3a的pT3b来比较疾病特异性生存率。

结果

经单一病理学家复查后,23例患者(53.5%)被确定为仅pT3b,20例患者(46.5%)为伴有pT3a的pT3b。仅pT3b患者的平均疾病特异性生存时间显著更长,为70.9±9.1(SE)个月,而伴有pT3a的pT3b患者为25.0±4.4(SE)个月(P = 0.0032)。单因素分析显示,pT3a因素的存在(P = 0.0065)、术前转移(P = 0.0025)、手术标本淋巴结转移阳性(P = 0.0183)和梭形细胞因素(P = 0.0233)被认为是预后不良的预测因素。

结论

pT3b期RCC患者存在肾周脂肪或肾上腺受累会使预后明显变差。术后应进行仔细检查,并对RCC的pT3b期伴有pT3a进行重新分类。

相似文献

1
Prognostic impact of perirenal fat or adrenal gland involvement in patients with pT3b renal cell carcinoma.肾周脂肪或肾上腺受累对pT3b期肾细胞癌患者的预后影响
Urology. 2007 May;69(5):839-42. doi: 10.1016/j.urology.2007.01.035.
2
Reclassification of the current tumor, node, metastasis staging in pT3 renal cell carcinoma.pT3期肾细胞癌当前肿瘤、淋巴结、转移分期的重新分类。
Int J Urol. 2008 Jul;15(7):582-6. doi: 10.1111/j.1442-2042.2008.02062.x. Epub 2008 May 8.
3
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.肾静脉及下腔静脉受累在肾细胞癌中的预后价值
Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.
4
Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.pT3a期透明细胞肾细胞癌中的肾窦脂肪浸润影响无淋巴结受累或远处转移患者的预后。
J Urol. 2009 May;181(5):2027-32. doi: 10.1016/j.juro.2009.01.048. Epub 2009 Mar 14.
5
Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.肾周脂肪浸润和肿瘤大小在肾细胞癌中的预后意义
J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.
6
Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.肾外肿瘤扩展的位置不影响pT3a期肾细胞癌患者的生存率。
J Urol. 2007 Nov;178(5):1878-82. doi: 10.1016/j.juro.2007.07.011. Epub 2007 Sep 17.
7
Real indications for adrenalectomy in renal cell carcinoma.肾细胞癌中肾上腺切除术的实际指征。
Scand J Urol Nephrol. 2002;36(4):273-7. doi: 10.1080/003655902320248236.
8
Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.几种组织病理学预后因素及局部肿瘤扩展对pT3b/c N0M0肾细胞癌肿瘤学结局的影响
BJU Int. 2009 Aug;104(4):461-9. doi: 10.1111/j.1464-410X.2009.08489.x. Epub 2009 Mar 11.
9
Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.评估肾细胞癌当前的TNM分类:修订T3a期。
J Urol. 2005 Jan;173(1):33-7. doi: 10.1097/01.ju.0000146719.43269.e8.
10
Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?肾细胞癌直接侵犯同侧肾上腺应归类为pT3a吗?
J Urol. 2005 Mar;173(3):918-21. doi: 10.1097/01.ju.0000153419.98715.24.

引用本文的文献

1
Recurrence pattern in patients with locally advanced renal cell carcinoma: The implications of clinicopathological variables.局部晚期肾细胞癌患者的复发模式:临床病理变量的影响
Arab J Urol. 2012 Jun;10(2):131-7. doi: 10.1016/j.aju.2011.12.007. Epub 2012 Feb 18.